Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances A Shepherd

Showing results (61-70 of 384) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Erlotinib for advanced non-small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21Paul Wheatley-Price, Keyue Ding, Lesley Seymour, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokersSinead Cuffe, Teng Moua, Ruth Summerfield, et al.
Bioinformatics (Oxford, England)|December 14, 2011
Optimized application of penalized regression methods to diverse genomic dataLevi Waldron, Melania Pintilie, Ming-Sound Tsao, et al.
Lung Cancer (Amsterdam, Netherlands)|September 29, 2005
A willingness-to-pay study of oral epidermal growth factor tyrosine kinase inhibitors in advanced non-small cell lung cancerNatasha B Leighl, W Stephen Tsao, Dianne L Zawisza, et al.
Cancer Medicine|June 19, 2021
The effect of prior cancer on non-small cell lung cancer trial eligibilityMichael Herman, Zhihui Liu, Frances A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Use of the epidermal growth factor receptor inhibitors gefitinib and erlotinib in the treatment of non-small cell lung cancer: a systematic reviewRon Feld, Srikala S Sridhar, Frances A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2009
Anticoagulation and bleeding: a pooled analysis of lung cancer trials of the NCIC Clinical Trials GroupAurélie Le Maître, Keyue Ding, Frances A Shepherd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2005
Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literatureGiannicola D'Addario, Melania Pintilie, Natasha B Leighl, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2015
Central Nervous System Pseudoprogression in a Patient Treated with PD-1 Checkpoint InhibitorMark K Doherty, Kevin Jao, Frances A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2013
A phase I study of pomalidomide (CC-4047) in combination with cisplatin and etoposide in patients with extensive-stage small-cell lung cancerPeter M Ellis, Ulf Jungnelius, Jennie Zhang, et al.
Pageof 39

Showing results (61-70 of 384) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Erlotinib for advanced non-small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21Paul Wheatley-Price, Keyue Ding, Lesley Seymour, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokersSinead Cuffe, Teng Moua, Ruth Summerfield, et al.
Bioinformatics (Oxford, England)|December 14, 2011
Optimized application of penalized regression methods to diverse genomic dataLevi Waldron, Melania Pintilie, Ming-Sound Tsao, et al.
Lung Cancer (Amsterdam, Netherlands)|September 29, 2005
A willingness-to-pay study of oral epidermal growth factor tyrosine kinase inhibitors in advanced non-small cell lung cancerNatasha B Leighl, W Stephen Tsao, Dianne L Zawisza, et al.
Cancer Medicine|June 19, 2021
The effect of prior cancer on non-small cell lung cancer trial eligibilityMichael Herman, Zhihui Liu, Frances A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Use of the epidermal growth factor receptor inhibitors gefitinib and erlotinib in the treatment of non-small cell lung cancer: a systematic reviewRon Feld, Srikala S Sridhar, Frances A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2009
Anticoagulation and bleeding: a pooled analysis of lung cancer trials of the NCIC Clinical Trials GroupAurélie Le Maître, Keyue Ding, Frances A Shepherd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2005
Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literatureGiannicola D'Addario, Melania Pintilie, Natasha B Leighl, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2015
Central Nervous System Pseudoprogression in a Patient Treated with PD-1 Checkpoint InhibitorMark K Doherty, Kevin Jao, Frances A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2013
A phase I study of pomalidomide (CC-4047) in combination with cisplatin and etoposide in patients with extensive-stage small-cell lung cancerPeter M Ellis, Ulf Jungnelius, Jennie Zhang, et al.
Pageof 39